Entry
Reader's guide
Entries A-Z
Subject index
National Treatment Improvement Evaluation Study
The National Treatment Improvement Evaluation Study (NTIES) was a congressionally mandated 5-year evaluation of the effectiveness of substance abuse treatment services delivered in comprehensive treatment demonstration programs supported by the Center for Substance Abuse Treatment (CSAT). The demonstration programs (Target Cities, Critical Populations, and Incarcerated and Non-incarcerated Criminal Justice Programs) provided treatment services to underserved and vulnerable populations whose drug problems tend to be more severe and who have few social supports to help in their recovery. Conducted from 1993 to 1995, NTIES built upon earlier national multisite treatment evaluation studies, including the Drug Abuse Reporting Program (1969–1973), the Treatment Outcome Prospective Study (1979–1981), the Drug Services Research Study (1989–1990), and the Drug Abuse Treatment Outcome Study (1991–1993). NTIES sought to answer questions about the following: (a) the use of demonstration funds, (b) enhancements that were deployed, (c) the number of programs and clients that were affected by the demonstration programs, (d) the extent to which the comprehensive treatment model has been validated and the evidence that more comprehensive treatment yields effective results in terms of client access to services and outcomes of treatment, and (e) the lessons that can be learned for future treatment about the implementation and cost of delivering comprehensive drug abuse services.
Study Design
NTIES was conducted by the National Opinion Research Center at the University of Chicago, in conjunction with the Research Triangle Institute. They used a two-level study design with an administrative level and clinical outcomes level. The administrative level of data provided information on treatment orientation, size, budget, staffing distribution, and specific use of CSAT funds in all service delivery units (SDUs) eligible to receive support through a CSAT demonstration grant. The clinical outcomes level collected data from clients enrolled in eligible units during three waves: shortly after their first day in treatment, when they left treatment, and then at 12 months after the end of treatment. The sample for the administrative level consisted of all of the SDUs that receive direct support as part of the CSAT demonstration programs. The clinical outcome data were collected from clients who received treatment from SDUs in a subsample of the NTIES SDUs.
The unit of analysis for the administrative component was the SDU, which could be a stand-alone treatment provider or one component of a multitiered treatment organization. The unit of analysis for the clinical outcomes portion was individual client data. Clinical outcomes of treatment were measured primarily through a before and after, or pretreatment to posttreatment, design.
Instrument Development
The forms developed for the administrative data collection were a baseline administrative report, an administrative update, an exit log, and a clinician form. The SDU administrators completed the baseline and update forms, which asked about staffing, facilities, costs and revenues, admissions procedures, client composition, services offered, and treatment philosophy. The exit log was a monthly report on client admissions and discharges. The clinician form was filled out by the clinicians on staff at NTIES SDUs. It was a brief questionnaire about demographics, training, and treatment philosophy.
The intake form, discharge form, 1-year follow-up questionnaire for clients, and records abstraction forms were the instruments developed for the clinical outcomes portion of the study. The intake and 1-year follow-up questionnaire collected data on family background, education, drug and alcohol use, living arrangements and social support, mental health, criminal activity, sources of financial support, physical health, and sexual behavior. The discharge form and records abstraction collected data on treatment experience, such as admission characteristics, services received during treatment, and the conditions of discharge from treatment.
...
- Behavioral Addictions
- Classifications of Drugs of Abuse
- Alcohol
- Amphetamines
- Amyl Nitrite
- Anabolic Steroids
- Anxiolytic Drugs
- Barbiturates
- Benzodiazepines
- Buprenorphine
- Caffeine
- Central Nervous System Depressants
- Central Nervous System Stimulants
- Club Drugs
- Cocaine and Crack
- Drugs, Classification of
- Ecstasy
- Fentanyl
- Hallucinogens
- Heroin
- Illicit and Illegal Drugs
- Inhalants
- Levo-Alpha Acetyl Methadol
- Marijuana
- Methadone
- Methamphetamine
- Methods of Drug Administration
- Morphine
- Naltrexone
- Opioids
- Over-the-Counter Drugs
- OxyContin
- Prescription Drugs
- Tobacco
- Criminal Justice System and Substance Abuse
- Engagement and Intervention
- Family and Community Issues
- Adult Children of Alcoholics
- Al-Anon
- Alateen
- Behavioral Couples Therapy
- Binge Drinking
- Brief Strategic Family Therapy
- Children of Alcoholics
- Codependency
- Community Reinforcement and Family Training
- Community Reinforcement Approach
- Enabling
- Experimental Substance Use
- Family Behavior Therapy
- Family Therapy
- Fetal Alcohol Syndrome
- Fetal Effects of Alcohol and Other Drugs
- Multidimensional Family Therapy
- Violence, Intimate Partner and Substance Abuse Treatment
- Models of Addiction
- Neurobiology of Addiction
- Prevention Theories, Research, Techniques, Strategies, and Effectiveness
- Alcohol Marketing
- Alternative Activities
- Behavioral Risk Factor Surveillance System
- Community-Based Processes
- Drug Abuse Resistance Education
- Environmental Approaches
- Evidence-Based Prevention
- Evidence-Based Prevention and Treatment, Dissemination and Adoption of
- Expectancies
- Fidelity of Prevention Programs
- Gateway Drugs Theory
- High-Risk Behaviors
- Information Dissemination
- Institute of Medicine Classification System
- Mentoring
- Monitoring the Future
- National Clearinghouse for Alcohol and Drug Information
- National Media Campaign
- National Outcome Measures
- National Registry of Evidence-based Programs and Practices
- National Survey on Drug Use and Health
- Prevention Education
- Prevention Evaluation
- Prevention Populations
- Prevention Resources
- Prevention Strategies
- Problem Identification and Referral
- Public Policy, Prevention
- Racial and Ethnic Minorities, Issues in Prevention
- Refusal Skills
- Risk and Protective Factor Theory
- Risk Factors for Addiction
- School-Based Prevention Programs
- Social Norms Marketing
- Social Skills Training
- Tobacco Marketing and Countermarketing
- Tobacco Master Settlement Agreement
- Underage Drinking
- Violence Prevention
- Professional Issues in Addictions
- Addiction Technology Transfer Centers
- American Society of Addiction Medicine
- Business Improvement Practices
- Centers for the Application of Prevention Technologies
- Certification and Licensing
- Clinical Supervision of Addiction Counselors
- College on Problems of Drug Dependence
- Confidentiality
- Dual Relationships
- Electronic Health Records
- Ethical Standards for Addiction Professionals
- Ethics
- Health Insurance Portability and Accountability Act
- Impaired Professionals
- Informed Consent
- International Coalition for Addiction Studies Education
- NAADAC, the Association for Addiction Professionals
- Network for the Improvement of Addiction Treatment
- Qualified Services Organization Agreements
- Single State Authorities
- State Provider Associations
- Public Policy Development
- Access to Recovery
- Center for Substance Abuse Prevention
- Center for Substance Abuse Treatment
- Comprehensive Drug Abuse Prevention and Control Act
- Decriminalization
- Demand Reduction
- Discrimination, Addicted and Recovering Individuals
- Drug Testing
- Drug-Free Schools and Communities Act
- Economic Costs of Alcohol and Drug Abuse
- Harm Reduction, Public Health
- Indian Health Services
- Insurance Parity
- Join Together
- Legal Action Center
- Legalization of Drugs
- Medical Use of Marijuana
- Moderation Approaches to Alcohol Problems
- National Council on Alcoholism and Drug Dependence
- National Drug Control Strategy
- National Epidemiologie Survey on Alcohol and Related Conditions
- National Institute of Mental Health
- National Registry of Evidence-based Programs and Practices
- Needle Exchange Programs
- Office of National Drug Control Policy
- Public Policy, Alcohol
- Public Policy, Drugs
- Public Policy, Prevention
- Public Policy, Treatment
- pulse Check
- Single State Authorities
- State Provider Associations
- Substance Abuse and Mental Health Services Administration
- Supply Reduction
- Synar Amendment
- Tobacco Master Settlement Agreement
- War on Drugs
- Recovery
- Al-Anon
- Alateen
- Alcoholics Anonymous
- Big Book, The
- Bill W.
- Cocaine Anonymous
- Double Trouble
- Dry Drunk Syndrome
- Gamblers Anonymous
- Moderation in Use
- Moderation Management
- Narcotics Anonymous
- Natural Recovery
- Peer Recovery Support Services
- Rational Recovery
- Recovery
- Recovery Community Organizations
- Recovery Community Services Program
- Recovery Schools
- Recovery Support Services
- Secular Organizations for Sobriety/Save Our Selves
- Sobriety
- Social Drinking
- Spiritual Issues
- Stigma
- Support Groups
- Twelve Steps
- Twelve-Step Recovery Programs
- Women for Sobriety
- Relapse Prevention
- Research and Evaluation Issues in Substance Abuse Prevention and Treatment
- Cannabis Youth Treatment Study
- College on Problems of Drug Dependence
- COMBINE Study
- Drug Abuse Treatment Outcome Studies
- Evidence-Based Prevention
- Evidence-Based Prevention and Treatment, Dissemination and Adoption of
- Evidence-Based Treatment
- Fidelity of Prevention Programs
- National Institute on Alcohol Abuse and Alcoholism
- National Institute on Drug Abuse
- National Institute on Drug Abuse Clinical Trials Network
- National Treatment Improvement Evaluation Study
- Prevention Evaluation
- Project MATCH
- Research Issues in Prevention
- Research Issues in Treatment
- Screening, Assessment, and Diagnosis
- Addiction Severity Index
- Alcohol Testing
- Alcohol Use Disorders Identification Test
- Alcohol-Induced Disorders
- Alcoholism
- Antisocial Personality Disorder
- Anxiety Disorders
- Assessment
- Assessment Instruments
- Borderline Personality Disorder
- CAGE Screening Instrument
- Co-Occurring Disorders
- Denial
- Depression
- Diagnosis
- Diagnostic and Statistical Manual of Mental Disorders
- Drug Abuse Screening Test
- Drug Testing
- Experimental Substance Use
- Inventory of Drinking Situations
- Michigan Alcohol Screening Test
- Post-Traumatic Stress Disorder
- Problem Oriented Screening Instrument for Teenagers
- Psychosocial History
- Screening
- Screening Instruments
- Self-Report Inventories
- Substance Abuse
- Substance Abuse Subtle Screening Inventory-3
- Substance Dependence
- Substance Use Disorders
- Substance-Induced Disorders
- Substance-Induced Withdrawal Delirium
- Timeline Followback
- Tolerance
- Urine Toxicology Testing
- Withdrawal
- Sociocultural and Historical Perspectives on Drug use
- Special Populations: Etiology, Prevention, and Treatment
- Adolescents, Substance Abuse and Treatment
- Antisocial Personality Disorder
- Anxiety Disorders
- Athletes and Drug Use
- Borderline Personality Disorder
- Children of Alcoholics
- Co-Occurring Disorders
- College Students, Alcohol Use and Abuse
- College Students, Drug Use and Abuse
- Criminal Justice Populations
- Depression
- Disabilities, Issues in Prevention and Treatment
- Elderly Populations, Treatment Issues
- Fetal Alcohol Syndrome
- Fetal Effects of Alcohol and Other Drugs
- Gay, Lesbian, Bisexual, and Transgender Issues
- Gender Issues
- Homeless, Substance Abuse and Treatment
- Maternal Drug Use
- Multiculturalism
- Post-Traumatic Stress Disorder
- Racial and Ethnic Minorities, Issues in Alcohol and Other Drug Use
- Racial and Ethnic Minorities, Issues in Prevention
- Racial and Ethnic Minorities, Issues in Treatment
- Special Populations
- Veterans, Substance Abuse and Treatment
- Welfare Reform and Substance Abuse
- Substance Abuse Health-Related Issues
- Alcohol-Related Birth Defects
- Amotivational Syndrome
- Antidepressant Drugs
- Antipsychotic Drugs
- Antiseizure Drugs
- Anxiolytic Drugs
- Attention Deficit Hyperactivity Disorder
- Blood Alcohol Concentration
- Drug Abuse Warning Network
- Fetal Alcohol Syndrome
- Fetal Effects of Alcohol and Other Drugs
- Grief, Loss, and Substance Abuse
- Health Care System and Substance Abuse
- Hepatitis C
- HIV/AIDS
- Injection Drug Use
- Insurance Parity
- Maternal Drug Use
- Medical Consequences
- Medical Use of Marijuana
- Methods of Drug Administration
- Pain Management
- Sexually Transmitted Diseases
- Suicide
- Tuberculosis
- Substance Abuse in the Workplace and School
- Treatment Theories, Research, Techniques, Strategies, and Effectiveness
- Abstinence Violation Effect
- Acamprosate
- Acceptance and Commitment Therapy
- Antabuse (Disulfiram)
- Antisocial Personality Disorder
- Anxiety Disorders
- Aversive Therapy
- Behavioral Couples Therapy
- Borderline Personality Disorder
- Brief Interventions
- Brief Strategic Family Therapy
- Buprenorphine
- Cannabis Youth Treatment Study
- CENAPS Model
- Client Engagement
- Client/Treatment Matching
- Co-Occurring Disorders
- Cognitive Behavioral Therapy
- Cognitive-Social Learning Model
- COMBINE Study
- Community Reinforcement and Family Training
- Community Reinforcement Approach
- Contingency Management
- Continuum of Care
- Counseling Approaches
- Court-Mandated Treatment
- Covert Sensitization
- Craving
- Depression
- Detoxification
- Drug Abuse Treatment Outcome Studies
- Evidence-Based Prevention and Treatment, Dissemination and Adoption of
- Evidence-Based Treatment
- Family Behavior Therapy
- Family Therapy
- Gender Issues
- Grief, Loss, and Substance Abuse
- Group Therapy and Counseling
- Harm Reduction Psychotherapy
- Inventory of Drinking Situations
- Levo-Alpha Acetyl Methadol
- Matrix Model
- Methadone Maintenance Treatment
- Minnesota Model
- Moderation Approaches to Alcohol Problems
- Moderation in Use
- Motivational Enhancement Therapy
- Motivational Interviewing
- Multidimensional Family Therapy
- Naloxone
- Naltrexone
- National Outcome Measures
- National Treatment Improvement Evaluation Study
- Nicotine Replacement Therapy
- Outpatient Treatment
- Patient Placement Criteria
- Pharmacological Approaches to Treatment
- Post-Traumatic Stress Disorder
- Project MATCH
- Public Policy, Treatment
- Qualified Services Organization Agreements
- Racial and Ethnic Minorities, Issues in Treatment
- Rapid Opioid Detoxification
- Relapse
- Relapse Prevention
- Residential Treatment
- Resistance in Treatment
- Solution-Focused Therapy
- Stages of Change Model
- Substitute Addictions
- Support Groups
- Synanon
- Therapeutic Communities
- Tobacco Cessation Programs and Treatments
- Treatment Access and Retention
- Treatment Approaches and Strategies
- Treatment Effectiveness
- Treatment Facilities
- Treatment in Jails and Prisons
- Treatment of Alcohol and Drug Use Disorders
- Treatment Plans and Treatment Planning
- Treatment Programs for Alcohol or Drug Abuse
- Treatment Settings
- Treatment, Nontraditional Approaches
- Twelve-Step Facilitation
- Veterans, Substance Abuse and Treatment
- Violence, Intimate Partner and Substance Abuse Treatment
- Loading...
Get a 30 day FREE TRIAL
-
Watch videos from a variety of sources bringing classroom topics to life
-
Read modern, diverse business cases
-
Explore hundreds of books and reference titles
Sage Recommends
We found other relevant content for you on other Sage platforms.
Have you created a personal profile? Login or create a profile so that you can save clips, playlists and searches